PFCS
TNYA icon

Pale Fire Capital SE’s Tenaya Therapeutics TNYA Stock Holding History

Pale Fire Capital SE’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,100
Closed -$91K – 74
2023
Q4 		$91K Hold
28,100
– – 0.01% 65
2023
Q3 		$71.7K Buy
+28,100
New +$118K 0.01% 62

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pale Fire Capital SE's TNYA Position: Q1 2024 in Review

Pale Fire Capital SE sold out of Tenaya Therapeutics (TNYA) in Q1 2024, closing a stake of 28,100 shares — an estimated $91K sold.

Pale Fire Capital SE first reported a position in TNYA in Q3 2023 and held it in 2 quarters. The position peaked at $91K in Q4 2023. 90 funds tracked by Wall St. Rank hold TNYA as of Q1 2024.

  • Pale Fire Capital SE reported no remaining Tenaya Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 28,100 Tenaya Therapeutics shares in Q1 2024, an estimated $91K.
  • Pale Fire Capital SE first reported a position in Tenaya Therapeutics in Q3 2023 and held it in 2 quarters.
  • Pale Fire Capital SE's Tenaya Therapeutics position peaked at $91K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2024.

Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.